Samsung Biologics Completes Acquisition of US Manufacturing Facility

Samsung Biologics completes acquisition of US manufacturing facility

Samsung Biologics has closed the deal to acquire GSK’s facility in Rockville, Md., establishing the biopharmaceutical firm’s first manufacturing ba...

Samsung Biologics expands US presence with GSK Rockville site buy

Samsung Biologics acquires GSK’s Rockville site, boosting US capacity by 60,000 liters and advancing supply-chain resilience for critical medicines.

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics’ geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support Plans further investments to add capabilities and strengthen long-term operations at the Rockville site INCHEON, South Korea and ROCKVILLE, MD., March 31, 2026 /PRNewswire/ — Samsung […]